Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Diabete Mellitus Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

5 recruiting trials for Diabete Mellitus. Eligibility criteria explained in plain English.

TrialFinderData lists 5 Diabete Mellitus clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Research is led by Forschungsinstitut der Diabetes Akademie Mergentheim (1), Xijing Hospital (1), VUNO Inc. (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is VUNO Med®-Fundus AI™ (device, 1 trial), followed by blood test.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
5
Total Trials
5
Recruiting Now
0
Phase 3 Trials
5
Sponsors

Track Diabete Mellitus trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT07212075

Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups

Mental conditions and disorders (e.g. distress, depressive, anxiety, and eating disorders) are more prevalent in people with diabetes (PWD) and associated with reduced quality of...

Sponsor: Forschungsinstitut der Diabetes Akademie MergentheimEnrolling: 18093 locations
RECRUITINGNCT07180368

Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients

The purpose of this observational study is to understand the impact of polypharmacy on the prognosis of elderly patients with chronic diseases. The main research question it aims...

Sponsor: Xijing HospitalEnrolling: 20001 location
RECRUITINGNCT07378956

Clinical Efficacy of Implementing an AI-SaMD for Funduscopy Analysis in Patients With Diabetes Mellitus

The objective of this study is to investigate the efficacy of implementing the AI-SaMD(VUNO Med®-Fundus AI™) alongside routine clinical practice for the detection of diabetic...

Sponsor: VUNO Inc.Enrolling: 3401 location
RECRUITINGNCT07550777

Serum Cholinesterases, Paraoxonase, and Cardiovascular Risk After Intravitreal Bevacizumab

Bevacizumab, an anti-VEGF (vascular endothelial growth factor) agent used in the treatment of diabetic retinopathy and macular edema associated with retinal vein occlusion, is...

Sponsor: Ataturk UniversityEnrolling: 1801 location
RECRUITINGNCT07605572

Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity

Diabetes mellitus (DM), prediabetes, and obesity are emerging as major global public health problems, with their epidemic spread continuously increasing over the past decades. The...

Sponsor: Attikon HospitalEnrolling: 1001 location

Frequently Asked Questions

There are currently 5 clinical trials for Diabete Mellitus, with 5 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Diabete Mellitus, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Diabete Mellitus, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.